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Abstract 
Previous estimates have indicated that in 2005, there 
were 4,072 individuals with dementia (IWD) in the 
Maltese islands and that this number would almost double 
by the year 2050. These figures were based on the 
EURODEM project that analysed the results of a 
population-based systematic review of published studies 
on the global prevalence of dementia from 1980 to 2004. 
Since then, further dementia prevalence studies have been 
carried out in Europe. These were reviewed in another 
European funded project, the EUROCODE project, with 
the aim of developing consensual European age and 
gender specific prevalence rates that would be acceptable 
for all countries. Using these revised rates, the estimated 
number of IWD over 60 years of age in the Maltese islands 
in 2010 was found to be 5,198; a significant increase on 
previous projected data. Likewise, the number of IWD in 
Malta over 60 years in 2030 is projected to be close to 
10,000 persons or 2.3% of the total Maltese population. 
Using these revised estimates, the 2% prevalence rate of 
dementia among the local population is expected to be 
reached by 2025; twenty-five years prior to what was 
previously reported. The data presented here include 
current updated estimates and projections for the number 
of IWD in the Maltese islands. 
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Introduction 
Dementia is an umbrella term that refers to a 
number of different medical disorders characterized by 
a progressive decrease in cognitive functions. Such 
cognitive decline includes the loss of memory and 
deterioration in executive functions such as planning 
and organizational skills, accompanied by a 
personality change and deterioration in cognitive 
function sufficient to influence social activities.
1
 
Alzheimer’s disease is the most common type of 
dementia accounting for almost 70% of cases. Other 
types include vascular dementia, dementia with Lewy 
bodies and frontotemporal dementia.
1,2 
The dementia syndrome has long been considered 
as a ‘silent epidemic’ and one of the major challenges 
of this century, posing ever increasing demands on all 
health care and social systems around the world.
3  
It is 
estimated that the worldwide cost of dementia was 
approximately €435 billion in 2010; accounting for 
around 1% of the world’s gross domestic product.4 A 
significant percentage of these costs occur in Western 
Europe and North America and are attributed to 
informal care (unpaid care provided by family and 
others), community and residential care and direct 
costs of primary and secondary medical care.
4 
According to the latest global estimates, there 
were 35.6 million people with dementia in 2010, with 
numbers nearly doubling every 20 years, to reach 65.7 
million in 2030 and 115.4 million in 2050 (Table 1).
5 
These estimates are 10% higher than previous reported 
data.
6
 This increase in both prevalence and incidence 
of dementia is mainly due to an ageing population 
worldwide. The last fifty years were characterized by a 
significant increase in individuals over the age of 60 
years, a figure that is expected to reach 22% of the 
population by the year 2050.
7
 Furthermore, the 
increase in the number of IWD will be more marked in 
developing countries.
7
 Thus, it is estimated that over 
the next twenty years, there will be a further 40% 
increase in IWD numbers in Europe, 63% in North 
America, 77% in the southern Latin American 
continent and 89% in the developed Asia Pacific 
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countries. However, among developing countries, such as 
those in Asia and North Africa, the increase in IWD will 
be over 100% over the next 20 years.
5 
 
 
Region 
Number of individuals with dementia  
(IWD, millions) 
 2010 2030 2050 
Asia 15.94 33.04 60.92 
Europe 9.95 13.95 18.66 
The Americas 7.82 14.78 27.08 
Africa 1.86 3.92 8.74 
World 35.56 65.69 115.38 
Table 1: Global estimates of the number of IWD for the years 
2010, 2030, 2050 by world region (adapted from World 
Alzheimer’s Report, 2009).5 
 
 
Similar to the global estimates, recent epidemiological 
studies across Europe reveal that the previous age and 
gender specific prevalence rates were underestimating the 
number of IWD. The prevalence rates obtained from the 
EURODEM project were based on studies that 
commenced in the 1980’s, and did not include data from 
Eastern Europe. As a result, the EUROCODE project was 
developed by Alzheimer Europe and funded by the 
European Commission with the aim of developing 
consensual prevalence rates for Alzheimer´s disease and 
other forms of dementia to be used by all the network 
partners. Following a systematic review and collaborative 
analysis of population based studies, the age and gender 
specific prevalence rates have been estimated using 
prevalence data indicated in Table 2.
8
 Using these findings, 
in combination with prevalence rates of early-onset 
dementia as obtained from EURODEM data, it was 
estimated that in 2006 there were 7.3 million IWD in 
Europe, equivalent to 12.5 per 1,000 inhabitants.
9
  The 
data presented here reports more accurate estimates of the 
current and projected number of IWD in the Maltese 
islands using EUROCODE criteria. 
 
Methods 
The methodology used to determine the number of 
IWD in the Maltese islands was similar to the one reported 
in a previous study.
10
 Since the EUROCODE prevalence 
rates start from the age of 60, the resulting estimates did 
not include individuals with early-onset dementia. 
Moreover, a recent systematic review acknowledged the 
difficulty in obtaining accurate prevalence rates for this 
age group, since there was a wide variation in the rates 
across studies.
8
 Nonetheless, early-onset dementia 
remains a rare condition with a relatively low number 
of cases resulting in an insignificant impact on the 
overall number of IWD.
 
 
 
Data on the five-year cohort age distribution of the 
Maltese population over the age of 60 in 2010 was 
obtained from the Malta National Statistics Office.
11
 
The projected total male and female population 
distributed over a five-year age cohort for the next 50 
years was obtained from EUROSTAT.
12
 The number 
of elderly in the 75-79, 80-84 and 85+ age groups for 
the projected years was then estimated. The number of 
IWD according to gender and age group was 
determined using the prevalence rates as indicated in 
the EUROCODE study. 
 
 
Age 
Range 
Prevalence rates 
of dementia 
(M/F) 
Total 
population in 
2010* (M/F) 
Estimated 
number of 
IWD (M/F) 
60-64 0.2/0.9 14931/15416 30/139 
65-69 1.8/1.4 9929/10997 179/154 
70-74 3.2/3.8 7566/9096 242/346 
75-79 7.0/7.6 5236/7593 367/577 
80-84 14.5/16.4 3090/5088 448/834 
85-89 20.9/28.5 1562/2911 326/830 
>90 30.8/46.6 510/1220 157/569 
Estimated total number of IWD 
5198 
(1.24%**) 
Table 2: EUROCODE project gender-specific prevalence 
rates of dementia
8
 and estimated number of IWD in the 
Maltese islands according to age bracket and gender. Data 
shown as M/F (M: males; F: females). *NSO data for 
2010,
11
 **percentage relative to Maltese population in 2010. 
 
 
Results 
The number of IWD in the Maltese islands in 2010 
according to gender and age groups, starting from 60 
years of age is shown in Table 3. As expected, from 
prevalence rates, dementia is more common in females 
compared to males with a significant increase in 
almost all age groups, especially in the oldest-old (80 
years and over). This increase is the most significant 
difference to be observed between the EURODEM and 
EUROCODE prevalence rates (Figure 1).  The 
estimated number of IWD over the age of 60 years 
was found to be approximately 5,200, an increase of 
18% over the previous estimates. In 2010, female 
individuals with dementia outnumbered males by a 
ratio of 2:1.  
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The revised projected figures for male and female 
IWD for the years 2015 to 2060 is shown in Table 3. The 
data indicate more than doubling in the number of 
dementia cases in the next 50 years reaching an estimated 
14,037 individuals in 2060. This will account to 3.6% of 
the total Maltese population in that year. Further analysis 
of the results also show that the 2% mark in the number of 
IWD is expected to be reached twenty-five years prior the 
previous estimates using the EURODEM data.
10 
Furthermore, the plateau that was expected by the year 
2025 will not occur until 2040.  
 
 
Age 
groups 
 2015 2020 2030 2040 2050 2060 
60-64 
M 
F 
27 
124 
27 
127 
21 
100 
27 
123 
29 
127 
25 
105 
65-69 
M 
F 
240 
201 
223 
186 
217 
177 
198 
164 
234 
193 
246 
185 
70-74 
M 
F 
246 
344 
381 
513 
376 
493 
292 
391 
382 
488 
419 
507 
75-79 
M 
F 
419 
601 
446 
616 
671 
871 
677 
847 
639 
800 
777 
959 
80-84 
M 
F 
493 
945 
620 
1038 
1100 
1672 
1154 
1681 
946 
1380 
1306 
1784 
>85 
M 
F 
619 
1812 
750 
2248 
1164 
3021 
2012 
4806 
2337 
5400 
2356 
5368 
Total 
IWD 
 6071 7175 9883 12372 12955 14037 
% of the 
total 
pop. 
 1.47 1.73 2.37 3.04 3.26 3.62 
Table 3: Estimated number of gender-specific dementia cases in 
the Maltese islands according to age groups using EUROCODE 
data for the years 2015 to 2060 based on EUROSTAT 
demographic projections.
12
 Data shown as M/F (M: males; F: 
females). 
 
 
Figure 1: Comparison of EURODEM (solid line) and 
EUROCODE (broken line) age specific prevalence rates in 
women 60 years of age and over. 
Discussion 
Similar to the revised global and European figures, 
the data presented here indicate that the number of 
IWD in the Maltese islands is expected to be 
significantly higher than previously reported. In 
contrast to EURODEM, EUROCODE data incorporate 
prevalence rates originating from the oldest-old female 
age groups, the latter being under reported in previous 
estimation studies.  
 
The revised estimates continue to highlight the 
need of increasing awareness concerning dementia 
management and care not only among the public but 
also health care professionals who will be directly 
involved with patients, relatives and caregivers. Indeed, 
more than three fourths of the 36 million individuals 
with dementia worldwide have not been diagnosed and 
therefore may not have access to information, 
treatment and care.
13
 This dearth in diagnosis has been 
attributed to various factors including the false belief 
that ‘nothing can be done’ or that ‘dementia is part of 
the ageing process’. Improving the likelihood of 
earlier diagnosis can be improved by increasing 
medical practice-based educational programs in 
primary care, introducing accessible diagnostic and 
early stage dementia care services such as memory 
clinics, and promoting effective interaction between 
different components of the health system.
13 
The revised data also present a number of 
challenges to policymakers in planning services 
targeted towards these individuals in the various levels 
of care settings.  Recently, a number of 
recommendations were presented by the Malta 
Dementia Strategy Group in order to consider, plan 
and develop services that provide high-quality care for 
individuals with dementia in Malta.
14 
Nevertheless, 
considering the significant increase in the number of 
dementia cases in the near future, there remains an 
urgent need to provide community support. The lack 
of assistance available to Maltese informal caregivers, 
especially with regards to financial support in 
purchasing anti-dementia medication, has also been 
recently highlighted.
15 
Moreover, it has been estimated 
that in the UK, up to a quarter of patients in general 
acute care settings at any one time, have dementia.
16 
This continues to highlight the need for health care 
professionals and administrators working in our local 
acute settings to be trained in high-quality dementia 
management and care. 
 
In line with other European countries, our data has 
shown that the vast majority of individuals with 
dementia are women. This is partly due to the fact that 
locally, life expectancy is higher in women compared 
to males. Therefore, policymakers have to take into 
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account the specific needs of women in the development 
of future social and health care plans.
17
 There is also a 
need for facilitating access to research funding in the field 
of dementia, especially on the impact that this condition 
will have on the socio-economic development of future 
generations. 
 
Although the findings reported here present a more 
accurate estimate of the number of IWD in the Maltese 
islands, there are methodological limitations. First, the 
EUROCODE project does not include prevalence rates for 
early-onset dementia. Thus, the estimates focus 
exclusively on individuals aged 60 years and over. As a 
result, the real number of existent cases would be expected 
to be higher. Secondly, epidemiological studies on which 
the EUROCODE prevalence rates have been formulated 
carry limitations of their own including different clinical 
criteria in diagnosis which may have resulted in 
differences in age-specific prevalence rates between 
countries. Moreover, the sampling criteria used across 
different European countries vary widely. The inclusion 
and exclusion criteria and the types of stratification 
employed across these studies also vary. Another limiting 
factor is the poor response rate, whilst few meta-analytic 
studies sought to examine the characteristics of non-
respondents. Finally, the following projections depend on 
the assumption that there were no changes in the mortality 
and birth rates, and that no effective prevention strategies 
or curative treatment were in place or would be developed 
in the future.
18 
 
In conclusion, the data presented show a significant 
increase in the current number of individuals with 
dementia among the Maltese population compared to 
previous estimates. Furthermore, there may be a 
significant increase in the number of IWD reaching 3.6 
percent of the population over the next fifty years. This 
will invariably put greater demands on health care services 
resulting in considerable socio-economic consequences. In 
order to face these present and future challenges, dementia 
care and management should be considered as among the 
most important health priorities in the Maltese islands.  
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